GPACTS 2026, the Global Pharma AI, Compliance and Technology Summit, will bring its flagship edition to Novotel Hyderabad Convention Centre (HICC) on September 3, 2026, convening an expected 350-400 senior decision-makers from pharmaceutical technology, manufacturing, quality, compliance, data and cybersecurity.

The summit arrives at a defining moment for the pharmaceutical industry, as companies accelerate investments in Artificial Intelligence (AI), connected manufacturing and data-led operations while facing greater scrutiny around validation, data integrity, cybersecurity and regulatory compliance. GPACTS Hyderabad will examine how the sector can scale digital transformation without weakening the controls required in regulated manufacturing environments.

GPACTS is built specifically around the realities of regulated pharmaceutical operations. It brings enterprise technology and business leadership into direct conversation with the manufacturing, quality and compliance functions responsible for implementation. The Hyderabad agenda will address responsible AI and governance in validated environments, evolving data-protection requirements, manufacturing cybersecurity, digital batch processes, manufacturing execution systems, laboratory software, connected quality systems and digital twins.

Confirmed speakers include Dr. Ajaz Hussain, Former Director, US Food and Drug Administration (FDA); Ramanarayana Parhi, Vice President (VP) and CIO, Alkem Laboratories; Rajesh T, Digital Transformation Head, Dr. Reddy’s Laboratories; AVPS Chakravarty, Chairman, Federation of Pharma Entrepreneurs (FOPE); Dr. Sridhar Reddy, Honorary Secretary, Indian Pharmaceutical Alliance (IPA); Sarvesh Singh, CEO, Telangana Life Sciences; Dr. Deepa Pangaonkar, Vice President (VP)–Quality IT, Wockhardt; Karthick Raja, CIO, Granules India; and Praveen Kumar Baheti, VP– IT, Biological E.

The wider programme will include leaders from pharmaceutical enterprises, technology organisations and advisory firms.

The Hyderabad edition is Powered by Honeywell, with support from Thermo Fisher Scientific, Rockwell Automation and Nividous Software. The participation of these organisations strengthens the summit’s focus on connected operations, automation, manufacturing intelligence, laboratory and quality systems, and enterprise transformation.

Shipra Singh, Director, GPACTS, said, “Pharma’s AI and digital-transformation agenda can no longer be separated from manufacturing, quality and compliance. GPACTS is being built as the platform where the leaders responsible for these decisions can confront the operational and regulatory realities together—and move the conversation from ambition to accountable implementation.”

The summit is intended for senior professionals from pharmaceutical manufacturing, IT, digital transformation, quality, compliance, data, automation and cybersecurity functions, along with selected technology and advisory organisations serving regulated life-sciences operations.